Bayer Group makes air polluter list; Netherlands promises India a halt to generics seizures;

> Bayer Group tops the Toxic 100 Air Polluters list published by the Political Economy Research Institute. Release | List

> The Netherlands has assured India that the incidents of generic drugs seizures in Europe would not recur once the European Commission amends its regulations. Report

> Lorus Therapeutics has completed the cGMP production of the first clinical batch of its anticancer drug candidate LOR-253. Release

> AMPAC Fine Chemicals, a subsidiary of American Pacific Corp., has expanded outside its California base with a multi-purpose manufacturing facility for APIs and intermediates in LaPorte, TX. Announcement

> Consultancy GxPi has been formed by the merger of GxP Consulting and Good Products, providers of consulting services and SharePoint document management solutions. Item

Suggested Articles

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.

Boehringer Ingelheim is investing $50 million in an animal health plant in Puerto Rico, adding 105 jobs.

Teva will begin producing chemo drug vincristine in the U.S. but has resisted the idea that its withdrawal from the market led to a shortage.